BackgroundPre-exposure prophylaxis (PrEP) has been shown to be highly effective for the prevention of HIV in clinical trials and demonstration projects, but PrEP uptake and adherence outside of these settings in the United States has been limited. Lack of knowledge and willingness of health care providers (HCPs) to prescribe PrEP is an important barrier to implementation.ObjectiveThe objective of this study was to describe and examine the feasibility and acceptability of a PrEP Optimization Intervention (PrEP-OI) targeted at HCPs. The ultimate purpose of this intervention was to increase PrEP uptake, adherence, and persistence among those at risk for HIV acquisition.MethodsThis intervention included the following: (1) a Web-based panel mana...
HIV infections have been, and continue to be, a significant health concern for the United States. Th...
Purpose of reviewRecent HIV outbreaks among people who use drugs (PWUD) necessitate additional HIV p...
BackgroundAntiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and recommended f...
Background:Pre-exposure prophylaxis (PrEP) has been shown to be highly effective for the prevention ...
ObjectiveThe HIV preexposure prophylaxis optimization intervention (PrEP-OI) study evaluated the eff...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
Background: Around 1.2 million people in the United States (U.S.) are currently infected with Human ...
Worldwide HIV rates have slowly been decreasing, except among men who have sex with men, where unfor...
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. There is little scientific ...
Practice Problem: Human Immunodeficiency Virus (HIV) is one of the leading pandemics in the world. I...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Purpose. This quality improvement project focused on educating primary care providers (PCPs) about p...
Antiretroviral drugs are being tried as candidates for the pre-exposure prophylaxis (PrEP) against H...
A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabr...
HIV infections have been, and continue to be, a significant health concern for the United States. Th...
Purpose of reviewRecent HIV outbreaks among people who use drugs (PWUD) necessitate additional HIV p...
BackgroundAntiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and recommended f...
Background:Pre-exposure prophylaxis (PrEP) has been shown to be highly effective for the prevention ...
ObjectiveThe HIV preexposure prophylaxis optimization intervention (PrEP-OI) study evaluated the eff...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
Background: Around 1.2 million people in the United States (U.S.) are currently infected with Human ...
Worldwide HIV rates have slowly been decreasing, except among men who have sex with men, where unfor...
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. There is little scientific ...
Practice Problem: Human Immunodeficiency Virus (HIV) is one of the leading pandemics in the world. I...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Purpose. This quality improvement project focused on educating primary care providers (PCPs) about p...
Antiretroviral drugs are being tried as candidates for the pre-exposure prophylaxis (PrEP) against H...
A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabr...
HIV infections have been, and continue to be, a significant health concern for the United States. Th...
Purpose of reviewRecent HIV outbreaks among people who use drugs (PWUD) necessitate additional HIV p...
BackgroundAntiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and recommended f...